Accessibility Menu
 
Decision Diagnostics logo

Decision Diagnostics

(OTC) DECN

Current Price$0.00
Market Cap$53,500
Since IPO (2002)-100%
5 Year-99%
1 Year+15,000%
1 Month+15,000%

Decision Diagnostics Financials at a Glance

Market Cap

$53,500

Revenue (TTM)

$2.13M

Net Income (TTM)

$8.78M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-4.50 (Low)

Price

$0.00

Volume

1

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

DECN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Decision Diagnostics

Industry

Health Care Technology

Headquarters

Westlake Village, CA 91361, US

DECN Financials

Key Financial Metrics (TTM)

Gross Margin

25%

Operating Margin

-1%

Net Income Margin

-15%

Return on Equity

0%

Return on Capital

-3%

Return on Assets

-5%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$53.50K

Shares Outstanding

354.50M

Volume

1

Avg. Volume

12.38K

Financials (TTM)

Gross Profit

$498.45K

Operating Income

$2.11M

EBITDA

$2.41M

Operating Cash Flow

$1.40M

Capital Expenditure

$3.00

Free Cash Flow

$1.40M

Cash & ST Invst.

$522.34K

Total Debt

$2.93M

Decision Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2021YOY CHG

Revenue

$518.51K

-0.4%

Gross Profit

$115.28K

+20.1%

Gross Margin

22.23%

N/A

Market Cap

$53.50K

N/A

Market Cap/Employee

$8.92K

N/A

Employees

6

N/A

Net Income

$554.92K

+88.3%

EBITDA

$490.72K

-74.4%

Quarterly Fundamentals

Name
Q3 2021YOY CHG

Net Cash

$3.03M

-10.0%

Accounts Receivable

$897.67K

-24.8%

Inventory

$165.61K

-12.1%

Long Term Debt

$0.00

N/A

Short Term Debt

$3.35M

-7.0%

Return on Assets

-5.25%

N/A

Return on Invested Capital

-2.90%

N/A

Free Cash Flow

$62.09K

+89.5%

Operating Cash Flow

$60.47K

+89.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
WIBFFWest Island Brands Inc.
$0.00+0.00%
AXMPAXM Pharma, Inc.
$0.00+0.00%
AMBSAmarantus BioScience Holdings, Inc.
$0.00+0.00%
ROTHPharmaRoth Labs, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%

Questions About DECN

What is the current price of Decision Diagnostics?

Decision Diagnostics is trading at $0.00 per share.

What is the 52-week range for Decision Diagnostics?

Over the past 52 weeks, Decision Diagnostics has traded between $0.00 and $0.00.

How much debt does Decision Diagnostics have?

Decision Diagnostics total debt is unavailable.

How much cash does Decision Diagnostics have on hand?

Decision Diagnostics does not have cash on hand data available.

What is Decision Diagnostics’s dividend yield?

Decision Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.